Leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth
Delivering solutions designed to relieve the high-throughput pressures of molecular diagnostic labs, QIAGEN provides a full range of clinical test analysis and interpretation services for germline and somatic indications.
Leveraging over 20 years of experience, expertise, and content curation, we address the specific needs of your lab, partnering with you to advance your precision medicine program.
Clinical Analysis and Interpretation Services:
Focus on downstream variant interpretation with managed services for automating, managing and standardizing your secondary analysis workflow.
Our offerings include software set-up, LIMS integration, pipeline optimization, on-demand variant calling through QIAGEN’s secure cloud, and quality control of failed samples.
Quickly grow your variant review and sign-out capacity with on-demand variant scoring and classification for germline and somatic indications.
Launch test offerings faster with custom literature curation services for any assay covering germline and somatic indications.
QIAGEN Clinical Analysis and Interpretation Services offer an all-in-one solution for storage, analysis and visualization of genetic data and results.
An oncology database with integrated visualization software that helps cancer researchers easily explore high-quality public and private cancer genomics datasets.
From setting up a new NGS pipeline to scaling existing operations, QIAGEN Clinical Analysis and Interpretation Services is here to help you maximize efficiency
Clinical decision support software powered by augmented molecular intelligence that helps clinical labs not only make faster decisions—but the right decisions.
Professional clinical interpretation service for molecular oncology testing labs offering rapid turnaround times and customized variant-level annotation for any somatic panel
Web-based application allowing you to harness genetic insights from QIAGEN’s real-world oncology dataset combined with knowledge from 2 decades of expert curation.